Showing results (1-10 of 148) with videos related to
Sort By:
Pageof 15
Expert Opinion on Emerging Drugs|May 23, 2013
Emerging drugs for neuroblastomaVictoria Castel, Vanessa Segura, Pablo BerlangaExpert Opinion on Emerging Drugs|March 4, 2017
Advances in emerging drugs for the treatment of neuroblastomaPablo Berlanga, Adela Cañete, Victoria CastelClinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2010
Treatment of high-risk neuroblastoma with anti-GD2 antibodiesVictoria Castel, Vanessa Segura, Adela CañeteJournal of Personalized Medicine|April 30, 2021
Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric SarcomasAntonio Juan Ribelles, Pablo Gargallo, Pablo Berlanga, et al.International Journal of Molecular Sciences|September 28, 2021
Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?Gladys G Olivera, Andrea Urtasun, Luis Sendra, et al.Journal of Pediatric Hematology/Oncology|March 2, 2016
Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution ExperiencePablo Berlanga, Adela Cañete, Marta Salom, et al.Journal of Pediatric Hematology/Oncology|November 7, 2014
Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution ExperiencePablo Berlanga, Adela Cañete, Roberto Díaz, et al.International Journal of Molecular Sciences|April 17, 2020
MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma PatientsGladys G Olivera, Yania Yáñez, Pablo Gargallo, et al.Pediatric Blood & Cancer|December 6, 2019
Metabolomic profiling in neuroblastomaGuillermo Quintás, Yania Yáñez, Pablo Gargallo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2017
Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP InhibitionElena Sanmartín, Lisandra Muñoz, Marta Piqueras, et al.Pageof 15